Nasdaq Combined Compos (COMPX.US)

Close: 12 355.00 (+156.37), Dec 1, 2020
Positive

Medium risk

Automatic technical analysis. Short term, Dec 1, 2020

Nasdaq Combined Composite Index has broken the rising trend up in the short term, which indicates an even stronger rising rate. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 11870 points. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the short term.

Recommendation one to six weeks: Positive (Score: 91)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.25%0.00+1.28%
5 days0.003.81%0.00+3.99%
22 days0.0010.49%0.00+10.46%
66 days0.0022.90%0.00+6.28%

More analyses of Nasdaq Combined Composite Index

chart Nasdaq Combined Composite Index (COMPX) Candlesticks 22 Days
Candlesticks
chart Nasdaq Combined Composite Index (COMPX) Short term
Short term: Positive
chart Nasdaq Combined Composite Index (COMPX) Medium term
Medium term: Positive
chart Nasdaq Combined Composite Index (COMPX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now